GenSight Biologics S.A. (GSGTF)
USD 0.32
(0.0%)
USD 0.32
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.69 Million EUR | -7.52% |
| 2022 | -32.23 Million USD | 7.2% |
| 2021 | -34.73 Million USD | -1.46% |
| 2020 | -34.23 Million USD | 11.62% |
| 2019 | -38.73 Million USD | 9.38% |
| 2018 | -42.74 Million EUR | -28.54% |
| 2017 | -33.25 Million EUR | -26.37% |
| 2016 | -26.31 Million EUR | -40.66% |
| 2015 | -18.7 Million EUR | -177.43% |
| 2014 | -6.74 Million EUR | -137.57% |
| 2013 | -2.83 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -8.61 Million USD | 0.0% |
| 2023 Q2 | -19.91 Million USD | 0.0% |
| 2023 Q4 | -14.5 Million USD | 0.0% |
| 2023 FY | -34.65 Million USD | -7.52% |
| 2022 FY | -32.23 Million USD | 7.2% |
| 2022 Q2 | -13.87 Million USD | 0.0% |
| 2021 FY | -34.73 Million USD | -1.46% |
| 2021 Q2 | -9.52 Million USD | 0.0% |
| 2020 Q4 | -14.42 Million USD | 0.0% |
| 2020 FY | -34.23 Million USD | 11.62% |
| 2020 Q2 | -18.18 Million USD | 0.0% |
| 2019 FY | -38.73 Million USD | 9.38% |
| 2019 Q2 | -22.35 Million USD | 0.0% |
| 2019 Q4 | -16.7 Million USD | 0.0% |
| 2018 Q2 | -15.56 Million USD | 0.0% |
| 2018 Q4 | -27.5 Million USD | 0.0% |
| 2018 FY | -42.74 Million EUR | -28.54% |
| 2017 FY | -33.25 Million EUR | -26.37% |
| 2016 FY | -26.31 Million EUR | -40.66% |
| 2015 FY | -18.7 Million EUR | -177.43% |
| 2014 FY | -6.74 Million EUR | -137.57% |
| 2013 FY | -2.83 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 58.633% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 704.214% |
| SQZ Biotechnologies Company | -75.82 Million USD | 60.836% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -66.392% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 136.28% |
| Mesoblast Limited | -84.14 Million USD | 64.709% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1833.272% |
| Genus plc | 6.4 Million USD | 564.0% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 404.81% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -3088.387% |
| Marizyme, Inc. | -34.08 Million USD | 12.881% |
| ContraFect Corporation | -56.88 Million USD | 47.8% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -255.641% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -551.982% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -2018.131% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -941.78% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -979.525% |
| MultiCell Technologies, Inc. | -722.81 USD | -4108310.232% |
| Accustem Sciences Inc. | -3.74 Million USD | -692.65% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 49.659% |
| EV Biologics, Inc. | -483.06 Thousand USD | -6047.451% |
| Q BioMed Inc. | -3.44 Million USD | -761.849% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 938.87% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -7522.764% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -1030.19% |
| Biomind Labs Inc. | -1 Million USD | -2841.354% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -508.581% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -346.69% |
| Skye Bioscience, Inc. | -13.67 Million USD | -117.206% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -1394.906% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -99045.299% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -488.683% |
| IMV Inc. | -38.67 Million USD | 23.21% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -87.123% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -1436.575% |
| GB Sciences, Inc. | -1.42 Million USD | -1990.518% |
| Alpha Cognition Inc. | -9.7 Million USD | -205.968% |
| HST Global, Inc. | -140.9 Thousand USD | -20974.893% |
| CSL Limited | 3.7 Billion USD | 100.802% |
| Halberd Corporation | -75.05 Thousand USD | -39468.288% |
| Enzolytics Inc. | -2.14 Million USD | -1281.981% |
| Resverlogix Corp. | -12.74 Million USD | -132.928% |
| Affymax, Inc. | -15.04 Million USD | -97.368% |
| SYBLEU INC | -149.18 Thousand USD | -19806.154% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -837.293% |
| argenx SE | -425.04 Million USD | 93.014% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 46.501% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -2744.444% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -1780.261% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -772.135% |
| AVAX Technologies, Inc. | 6.69 Million USD | 543.695% |
| Zenith Capital Corp. | -8.94 Million USD | -232.059% |
| Genscript Biotech Corporation | -415.79 Million USD | 92.858% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -170360.938% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -1109.457% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -17214.489% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 45.98% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -923.559% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -2917.724% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -1492.817% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -2264.331% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1381.277% |
| BioStem Technologies, Inc. | -7.77 Million USD | -281.747% |
| ONE Bio Corp. | 13.68 Million USD | 317.051% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -16262.785% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -2123.702% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -2539.865% |
| Agentix Corp. | -1.37 Million USD | -2064.816% |
| LadRx Corporation | -3.82 Million USD | -676.645% |
| Cell Source, Inc. | -4.32 Million USD | -586.558% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -7047.413% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -4222.876% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -4222.876% |
| NovAccess Global Inc. | -2.46 Million USD | -1103.846% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -917.18% |
| Itoco Inc. | -919.14 Thousand USD | -3130.846% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -600.639% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -2553.798% |
| Kadimastem Ltd | -3.04 Million USD | -876.762% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -11246.217% |
| CytoDyn Inc. | -18.05 Million USD | -64.448% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -117881.724% |
| Mobile Lads Corp. | -554.55 Thousand USD | -5254.973% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -13393.398% |
| Qrons Inc. | -643.67 Thousand USD | -4513.494% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -5158.507% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -1231.731% |
| Rebus Holdings, Inc. | -664 Thousand USD | -4372.289% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -1534.954% |
| International Stem Cell Corporation | -663 Thousand USD | -4379.035% |
| Bioxytran, Inc. | -3.82 Million USD | -677.352% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -56313.374% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -145898.033% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 18.116% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -1735.352% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -3935.687% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -854.548% |
| Neutra Corp. | -229.48 Thousand USD | -12840.223% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -69.314% |
| PureTech Health plc | -146.19 Million USD | 79.688% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -38.178% |
| IXICO plc | -1.43 Million USD | -1966.527% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -212.886% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 75.62% |
| CSL Limited | 3.81 Billion USD | 100.779% |
| Cellectis S.A. | -108.85 Million USD | 72.72% |